U.S. Patent and Trademark Office (PTO) NOTICE OF ALLOWANCE |
ISSUE DATE OF NOA: Jul 29, 2003
SUSAN M. FREEDMAN FINNEGAN, HENDERSON, FARABOW, GARRETT 1300 I STREET, N.W. WASHINGTON, D.C. 20005-3315 |
ATTORNEY REFERENCE NUMBER 03367.0502 |
** IMPORTANT INFORMATION: 6 MONTH DEADLINE ** Please note that both the "Statement of Use " and "Extension Request" have many legal requirements, including fees. These requirements are explained in the PTO booklet "Basic Facts About Trademarks", which can be obtained upon request at (703)308-9000. In addition, there are printed forms contained in this booklet (for "Statement of Use" and "Extension Requests") for your use. |
The following information should be reviewed for accuracy:
SERIAL NUMBER: | 76/459117 |
MARK: | ACTIFEM |
OWNER: | Novo Nordisk A/S |
Novo Alle DK-2880 Bagsvaerd , DENMARK |
Section 1(a): NO | Section 1(b): YES | Section 44(e): NO |
GOODS/SERVICES BY INTERNATIONAL CLASS
005 - | Pharmaceutical preparations, namely for prescription only oral hormone replacement therapy drug for treatment of menopausal symptoms and prevention of osteoporosis |
ALL OF THE GOODS/SERVICES IN EACH CLASS ARE LISTED
ADDITIONAL INFORMATION MAY BE PRESENT IN THE PTO RECORDS